Search

everythinglearnresearchcommunity

for

Search:↓

Genetic screening for NUDT15 polymorphisms is crucial for patients taking azathioprine, especially in Asians.

Azathioprine can cause unexpected hair loss and severe bone marrow issues, so careful monitoring is needed.

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

Managing malignant ureteral obstruction is challenging and requires personalized treatment to protect kidney function and patient health.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

Higher oxidative stress markers are linked to hair loss in post-COVID-19 patients.

Adipose-derived stem cells are promising for regenerative medicine due to their accessibility, versatility, and low risk of immune rejection.

Neurosteroids like allopregnanolone help control cell death and growth in the developing fetal brain.

Cannabidivarin (CBDV) may help brain cell growth and survival through the TRPV1 receptor.

Tamsulosin with Serenoa repens is as effective as with 5-alpha-reductase inhibitors but causes fewer side effects.

Long COVID-19 patients with skin pain might have a nerve condition that responds to a medication called gabapentin.

Neuropathic pruritus is a commonly overlooked and wrongly diagnosed type of chronic itching that is hard to treat.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

Chemotherapy worsens nutritional status in breast cancer patients, requiring targeted nutritional strategies.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

The new SLICC criteria for diagnosing lupus are more sensitive and accurate than the old criteria.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Thallium, mercury, selenium, and colchicine strongly cause hair loss.

Preventive measures and effective management are crucial for reducing skin side effects in cancer treatment.

The conclusion is that early diagnosis of skin signs linked to diseases like Lupus, Dermatomyositis, and Rheumatoid Arthritis is crucial to prevent serious complications.

In 2024, the FDA approved 27 innovative small-molecule drugs, with many offering significant treatment improvements.

Early detection and multidisciplinary management of skin and mouth side effects from breast cancer treatments improve patient outcomes.

Nanotechnology can improve cervical cancer treatment by targeting drugs better and reducing side effects.

Combining hyperthermia with natural compounds and conventional treatments improves cancer therapy effectiveness and reduces side effects.

Cytarabine can cause multiple organ toxicities, especially neurotoxicity, but better research methods are needed to fully understand and predict these effects.

Methimazole for hyperthyroidism has known and new side effects needing more study for safety.

New medications could improve treatment for severe alopecia areata in Australia.

Accurate diagnosis and personalized treatment are crucial in dermatopathology.

Alopecia Areata causes hair loss and needs treatments that address both physical and emotional health.